These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 1479291)

  • 1. Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipidemia.
    Moulin P; Appel GB; Ginsberg HN; Tall AR
    J Lipid Res; 1992 Dec; 33(12):1817-22. PubMed ID: 1479291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of lipoprotein-bound NEFAs in enhancing the specific activity of plasma CETP in the nephrotic syndrome.
    Braschi S; Masson D; Rostoker G; Florentin E; Athias A; Martin C; Jacotot B; Gambert P; Lallemant C; Lagrost L
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2559-67. PubMed ID: 9409228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles.
    Guerin M; Lassel TS; Le Goff W; Farnier M; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):189-97. PubMed ID: 10634817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidaemia.
    Guérin M; Bruckert E; Dolphin PJ; Chapman MJ
    Eur J Clin Invest; 1996 Jun; 26(6):485-94. PubMed ID: 8817163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM).
    Elchebly M; Porokhov B; Pulcini T; Berthezène F; Ponsin G
    Atherosclerosis; 1996 Jun; 123(1-2):93-101. PubMed ID: 8782840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjects.
    Lassel TS; Guérin M; Auboiron S; Chapman MJ; Guy-Grand B
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):65-74. PubMed ID: 9445258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
    Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
    Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.
    Guérin M; Le Goff W; Lassel TS; Van Tol A; Steiner G; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):282-8. PubMed ID: 11156866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia.
    Le Goff W; Guerin M; Chapman MJ
    Pharmacol Ther; 2004 Jan; 101(1):17-38. PubMed ID: 14729390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables.
    McPherson R; Mann CJ; Tall AR; Hogue M; Martin L; Milne RW; Marcel YL
    Arterioscler Thromb; 1991; 11(4):797-804. PubMed ID: 2065034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesteryl ester transfer activity in lipoprotein lipase deficiency and other primary hypertriglyceridemias.
    Iglesias A; Contreras JA; Martínez-Pardo M; Entrala A; Herrera E; Lasunción MA
    Clin Chim Acta; 1993 Nov; 221(1-2):73-89. PubMed ID: 8149644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of elevated lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients.
    Dullaart RP; Gansevoort RT; Dikkeschei BD; de Zeeuw D; de Jong PE; Van Tol A
    Kidney Int; 1993 Jul; 44(1):91-7. PubMed ID: 8355471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia.
    Guérin M; Bruckert E; Dolphin PJ; Turpin G; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):763-72. PubMed ID: 8640404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.
    Mann CJ; Yen FT; Grant AM; Bihain BE
    J Clin Invest; 1991 Dec; 88(6):2059-66. PubMed ID: 1752964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.
    Iglesias A; Arranz M; Alvarez JJ; Perales J; Villar J; Herrera E; Lasunción MA
    Clin Chim Acta; 1996 Apr; 248(2):157-74. PubMed ID: 8740580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro production of beta-very low density lipoproteins and small, dense low density lipoproteins in mildly hypertriglyceridemic plasma: role of activities of lecithin:cholester acyltransferase, cholesterylester transfer proteins and lipoprotein lipase.
    Chung BH; Segrest JP; Franklin F
    Atherosclerosis; 1998 Dec; 141(2):209-25. PubMed ID: 9862170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered transfer of cholesteryl esters and phospholipids in plasma from alcohol abusers.
    Liinamaa MJ; Hannuksela ML; Kesäniemi YA; Savolainen MJ
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2940-7. PubMed ID: 9409280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial cholesteryl ester transfer protein deficiency is associated with triglyceride-rich low density lipoproteins containing cholesteryl esters of probable intracellular origin.
    Bisgaier CL; Siebenkas MV; Brown ML; Inazu A; Koizumi J; Mabuchi H; Tall AR
    J Lipid Res; 1991 Jan; 32(1):21-33. PubMed ID: 2010691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid transfer inhibitor protein defines the participation of lipoproteins in lipid transfer reactions: CETP has no preference for cholesteryl esters in HDL versus LDL.
    Serdyuk AP; Morton RE
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):718-26. PubMed ID: 10073979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.